Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

Background & Aims: Direct comparisons across first-line regimens for advanced hepatocellular carcinoma are not available. We performed a network metanalysis of phase III of trials to compare first-line systemic treatments for hepatocellular carcinoma in terms of overall survival (OS), progre...

Full description

Bibliographic Details
Main Authors: Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Charalampos-Vlasios Stikas, Alessandra Gennari, Bruno Vincenzi, Mark R. Openshaw, Marianna Silletta, Matthias Pinter, Alessio Cortellini, Lorenza Scotti, Antonio D’Alessio, David J. Pinato
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:JHEP Reports
Subjects:
Targeted therapy
Tyrosine kinase inhibitors
Immune checkpoint inhibitors
First-line treatment
Liver cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555923000332

Internet

http://www.sciencedirect.com/science/article/pii/S2589555923000332

Similar Items